Method for treating sickle cell disease using quercetin-containing compositions
US12403123B2 · kind B2 · utility
0Cited by
9References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2022 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Jul 15, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compositions and methods for treating sickle cell disease. Also disclosed are methods of treating sickle cell disease comprising administering to a subject in need thereof an effective amount of isoquercetin, vitamin B3, vitamin C, and optionally folic acid and wherein the effective amount is sufficient to halt progression of one or more of the symptoms of sickle cell disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.